Use of Albuterol Multidose Dry Powder Inhaler in Participants With Chronic Obstructive Pulmonary Disease

Study Title
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Teva Identifier
ABS-COPD-30065
ClinicalTrials.gov Identifier
NCT03256695
Study Status
Completed
Trial Condition(s)
Chronic Obstructive Pulmonary Disease
Interventions
Drug: Albuterol sulfate (ABS)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial



Key Participation Requirements

Gender
Female, Male
Age Range
40 Years and older
Trial Duration
September 28, 2017 - April 17, 2018
Phase
Phase 3

Study Type

Interventional